Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Nonprevalent Amyotrophic Lateral Sclerosis Advanced Sequencing Evaluation Athena Diagnostics United States | 24 | 15 |
|
Amyotrophic Lateral Sclerosis Advanced Evaluation Athena Diagnostics United States | 19 | 17 |
|
Asper Biogene Asper Biogene LLC Estonia | 29 | 20 |
|
CeGaT GmbH Germany | 32 | 36 |
|
Frontotemporal Dementia (FTD) Panel CeGaT GmbH Germany | 29 | 28 |
|
Amyotrophic Lateral Sclerosis (ALS) Panel CeGaT GmbH Germany | 29 | 54 |
|
Hereditary Spastic Paraplegias (HSP) and differential diagnoses Panel CeGaT GmbH Germany | 147 | 143 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Amyotrophic Lateral Sclerosis NGS Panel Fulgent Genetics United States | 84 | 43 |
|
Laboratory of Human Genetics GENOMED Health Care Center Poland | 1 | 24 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.